Livzon Pharmaceutical Group ( (HK:1513) ) has issued an announcement.
Livzon Pharmaceutical Group Inc. has announced a meeting for its H shareholders to discuss and approve the renewal of the repurchase scheme for its A shares and to grant a mandate to the Board for repurchasing H shares. This move is aimed at optimizing the company’s capital structure and enhancing shareholder value, subject to regulatory approvals and compliance with applicable laws.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on the development, production, and sale of pharmaceutical products, serving both domestic and international markets.
YTD Price Performance: -0.29%
Technical Sentiment Signal: Buy
Current Market Cap: $3.93B
Learn more about 1513 stock on TipRanks’ Stock Analysis page.